07-17 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BU
07-16 Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026 BU
06-22 Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD BU
06-12 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BU
06-09 Scholar Rock Holding Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10:00 AM
05-26 Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference BU
05-20 Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference BU
05-15 Scholar Rock reports new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) RE
05-15 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BU
05-12 Scholar Rock Holding Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08:00 AM
05-07 Scholar Rock Holding Corporation, Q1 2026 Earnings Call, May 07, 2026
05-07 Scholar Rock Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-07 Scholar Rock Q1 Loss Widens MT
05-07 Earnings Flash (SRRK) Scholar Rock Posts Q1 Net Loss $0.83 a Share, vs. FactSet Est of $0.80 Loss MT
05-07 Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights BU
04-29 Scholar Rock to Present at the BofA Securities 2026 Health Care Conference BU
04-21 Canaccord Genuity Initiates Scholar Rock at Buy With $62 Price Target MT
04-21 Scholar Rock Holding Insider Sold Shares Worth $1,517,723, According to a Recent SEC Filing MT
04-20 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AQ
04-17 Scholar Rock reports new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) RE
04-17 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BU
04-16 Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026 BU
03-31 Scholar Rock Holding Corporation - Special Call
03-31 Scholar Rock Resubmits Biologics License Application For Apitegromab For Treatment Of Children And Adults With Spinal Muscular Atrophy CI
03-31 Wedbush Adjusts Price Target on Scholar Rock Holding to $58 From $56, Maintains Outperform Rating MT
No results match your criteria
  1. Stock Market
  2. Stocks
  3. SRRK Stock
  4. News Scholar Rock Holding Corporation